Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 1/20 | 0.43 |
| ▸ | PTGFR | P43088 | 1/20 | 0.43 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.43 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.41 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.41 |
| ▸ | SLCO2A1 | Q92959 | 1/20 | 0.39 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP12 | P39900 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6570849 | 0.81 | SLC18A2 (0.47) | SLC18A2 | |
| SCHEMBL4256995 | 0.78 | LTB4R (0.53) | PTGER1PTGFRPTGER2LTB4RLTB4R2 | |
| SCHEMBL31354792 | 0.77 | LTB4R (0.52) | PTGER1PTGFRPTGER2LTB4RLTB4R2 | |
| SCHEMBL6567840 | 0.76 | SLC18A2 (0.46) | SLC18A2 | |
| SCHEMBL4799370 | 0.75 | MMP2 (0.55) | DPP4MMP2MMP9MMP12MMP13 | |
| SCHEMBL2557825 | 0.74 | PTGER1 (0.42) | PTGER1PTGFRPTGER2LTB4RLTB4R2 | |
| SCHEMBL22350151 | 0.73 | PTGER1 (0.49) | PTGER1PTGFRPTGER2LTB4RLTB4R2 | |
| SCHEMBL22350147 | 0.73 | PTGER1 (0.49) | PTGER1PTGFRPTGER2LTB4RLTB4R2 | |
| SCHEMBL4256993 | 0.73 | MMP12 (0.47) | PTGER1PTGFRPTGER2DPP4MMP2 | |
| SCHEMBL27516839 | 0.72 | PTGER1 (0.48) | PTGER1PTGFRPTGER2LTB4RLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070092467-A1 | Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers | L'OREAL (FR) | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092467-A1 | Oxyacetamide compounds useful for stimulating or inducing the growth and/or retarding the loss of keratin fibers | HPGD, KRT18, PTGS1 | PTGER1 43/4885PTGFR 36/4885PTGER2 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.